Skip to main content

Table 3 Distribution and comparison of pre- and post-treatment evaluation results

From: Splinting in carpal tunnel syndrome—should we use it during the daytime?

 

Group 1

n (wrists) = 20

Median (IQR 25–75%), n (%)

Group 2

n (wrists) = 28

Median (IQR 25–75%), n (%)

Group 3

n (wrists) = 22

Median (IQR 25–5%), n (%)

P value

*p

Groups 1–2a

Groups 1–3a

Groups 2–3a

preT-VAS

70.0 (70.0–80.0)

70.0 (50.0–80.0)

80.0 (70.0–90.0)

0.353

   

postT-VAS

70.0 (45.0–80.0)

55.0 (32.50–70.0)

60.0 (40.0–70.0)

0.269

Ω, group exchange p

0.511

0.001

0.001

 

preT-median SNAP (µV)

42.45 (26.32–53.55)

43.05 (24.45–57.02)

27.20 (13.32–58.32)

0.387

   

postT-median SNAP (µV)

41.30 (29.10–71.52)

43.70 (30.17–57.42)

27.60 (14.25–58.75)

0.189

Ω, group exchange p

0.778

0.001

0.825

 

preT-median SCV (m/s)

33.40 (31.70–37.80)

35.40 (31.52–37.50)

31.60 (27.07–36.05)

0.081

   

postT-median SCV (m/s)

35.0 (30.25–38.07)

36.10 (33.12–38.70)

32.25 (28.07–36.45)

0.075

Ω,group exchange p

0.532

0.001

0.065

 

preT-median CMAP (mV)

8.0 (7.19–9.62)

8.65 (6.80–10.65)

7.20 (5.97–10.07)

0.213

   

postT-median CMAP (mV)

8.45 (6.55–10.20)

9.95 (7.80–11.95)

7.90 (5.87–10.10)

0.056

Ω, group exchange p

0.717

0.002

0.161

 

preT-median DML(ms)

4.01 (3.30–4.36)

3.46 (3.16–4.27)

3.95 (3.47–4.74)

0.108

   

postT-median DML (ms)

3.78 (3.31–4.44)

3.46 (3.11–3.88)

3.72 (3.26–4.14)

0.274

Ω, group exchange p

0.636

0.102

0.061

 

preT-median MCV (m/s)

55.50 (51.0–57.0)

54.0 (51.0–58.0)

54.0 (51.75–57.02)

0.993

   

postT-median MCV (m/s)

56.0 (52.50–59.50)

55.0 (51.25–59.0)

54.5 (52.25–57.02)

0.530

Ω, group exchange p

0.065

0.296

0.604

 

preT-BCTQ-SSS

2.72 (2.18–3.63)

2.72 (2.45–3.15)

3.81 (2.76–4.36)

0.048

0.920

0.037

0.007

postT-BCTQ-SSS

2.72 (2.04–3.18)

2.54 (2.09–3.24)

2.63 (2.30–3.79)

0.706

Ω, group exchange p

0.057

0.001

0.001

 

preT-BCTQ-FSS

2.37 (1.0–3.63)

2.43 (1.5–3.18)

3.37 (2.52–4.37)

0.058

   

postT-BCTQ-FSS

2.56 (1.03–3.75)

1.87 (1.10–3.0)

2.06 (1.26–4.0)

0.208

Ω, group exchange p

0.482

0.003

0.001

 

preT-NHP-pain

22.90 (13.94–72.90)

36.5 (12.91–70.22)

80.26 (41.68–88.07)

0.014

0.521

0.004

0.010

postT-NHP-pain

33.02 (12.91–87.70)

29.23 (12.91–52.53)

53.51 (33.92–59.40)

0.062

Ω, group exchange p

0.397

0.001

0.001

 

preT-NHP-ER

12.21 (0.0–26.58)

12.21 (0.0–45.75)

46.13 (10.47–67.26)

0.018

0.649

0.008

0.023

postT-NHP-ER

8.49 (0.0–26.58)

3.54 (0.0–100.0)

22.51 (0.0–58.44)

0.190

Ω, group exchange p

0.066

0.001

0.014

 

preT-NHP-sleep

37.30 (0.0–59.11)

27.26 (12.57–36.71)

65.06 (24.64–77.63)

0.047

0.363

0.025

0.004

postT-NHP-sleep

33.54 (0.0–59.11)

16.10 (0.0–56.91)

50.0 (0.0–68.20)

0.606

Ω, group exchange p

0.317

0.003

0.036

 

preT-NHP-energy

24.0 (0.0–100.0)

31.60 (24.0–100.0)

33.20 (60.60–100.0)

0.215

   

postT-NHP-energy

29.60 (6.0–100.0)

29.0 (0.0–55.40)

33.20 (54.80–76.63)

0.527

Ω, group exchange p

0.167

0.171

0.988

 

preT-NHP-PA

10.95 (0.0–32.81)

16.76 (0.0–33.31)

23.36 (8.65–46.14)

0.196

   

postT-NHP-PA

11.20 (0.0–32.81)

11.37 (0.0–30.66)

22.74 (19.37–45.17)

0.255

Ω, group exchange p

0.317

0.001

0.015

 

preT-NHP-SI

0.0 (0.0–15.97)

0.0 (0.0–11.54)

10.06 (0.0–35.33)

0.455

   

postT-NHP-SI

0.0 (0.0–15.97)

0.0 (0.0–63.20)

0.0 (0.0–20.72)

0.731

Ω, group exchange p

1.000

0.958

0.003

 

preT-NHP-total

117.91 (63.95–322.01)

112.90 (63.44–287.03)

276.65 (118.81–379.69)

0.056

   

postT-NHP-total

91.20 (43.64–322.01)

103.60 (49.48–285.59)

249.68 (111.40–384.33)

0.054

Ω, group exchange p

0.916

0.001

0.001

 
  1. VAS Visual Analog Scale, SNAP sensory nerve action potential, SCV sensorial conduction velocity, CMAP compound motor action potential, DML distal motor latency, MCV motor conduction velocity, BCTQ Boston Carpal Tunnel Questionnaire, NHP Nottingham Health Profile, SSS symptom severity status, FSS functional severity scale, ER emotional reactions, PA physical activity, SI social isolation, preT pre-treatment, postT post-treatment, IQR interquartile range
  2. p < 0.05 values were accepted as statistically significant
  3. *Among group comparisons—Kruskal–Wallis test
  4. aMann-Whitney U test
  5. Ω, within-group comparisons—Wilcoxon signed rank test